Literature DB >> 23116773

Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.

James P White1, Song Gao, Melissa J Puppa, Shuichi Sato, Stephen L Welle, James A Carson.   

Abstract

Low endogenous testosterone production, known as hypogonadism is commonly associated with conditions inducing muscle wasting. Akt signaling can control skeletal muscle mass through mTOR regulation of protein synthesis and FoxO regulation of protein degradation, and this pathway has been previously identified as a target of androgen signaling. However, the testosterone sensitivity of Akt/mTOR signaling requires further understanding in order to grasp the significance of varied testosterone levels seen with wasting disease on muscle protein turnover regulation. Therefore, the purpose of this study is to determine the effect of androgen availability on muscle Akt/mTORC1/FoxO3a regulation in skeletal muscle and cultured C(2)C(12) myotubes. C57BL/6 mice were either castrated for 42 days or castrated and treated with the nandrolone decanoate (ND) (6 mg/kg bw/wk). Testosterone loss (TL) significantly decreased volitional grip strength, body weight, and gastrocnemius (GAS) muscle mass, and ND reversed these changes. Related to muscle mass regulation, TL decreased muscle IGF-1 mRNA, the rate of myofibrillar protein synthesis, Akt phosphorylation, and the phosphorylation of Akt targets, GSK3β, PRAS40 and FoxO3a. TL induced expression of FoxO transcriptional targets, MuRF1, atrogin1 and REDD1. Muscle AMPK and raptor phosphorylation, mTOR inhibitors, were not altered by low testosterone. ND restored IGF-1 expression and Akt/mTORC1 signaling while repressing expression of FoxO transcriptional targets. Testosterone (T) sensitivity of Akt/mTORC1 signaling was examined in C(2)C(12) myotubes, and mTOR phosphorylation was induced independent of Akt activation at low T concentrations, while a higher T concentration was required to activate Akt signaling. Interestingly, low concentration T was sufficient to amplify myotube mTOR and Akt signaling after 24 h of T withdrawal, demonstrating the potential in cultured myotubes for a T initiated positive feedback mechanism to amplify Akt/mTOR signaling. In summary, androgen withdrawal decreases muscle myofibrillar protein synthesis through Akt/mTORC1 signaling, which is independent of AMPK activation, and readily reversible by anabolic steroid administration. Acute Akt activation in C(2)C(12) myotubes is sensitive to a high concentration of testosterone, and low concentrations of testosterone can activate mTOR signaling independent of Akt.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116773      PMCID: PMC3529800          DOI: 10.1016/j.mce.2012.10.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  80 in total

1.  Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.

Authors:  A M Kenny; K M Prestwood; C A Gruman; K M Marcello; L G Raisz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-05       Impact factor: 6.053

2.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

3.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

Authors:  C Rommel; S C Bodine; B A Clarke; R Rossman; L Nunez; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

4.  Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

Authors:  S Bhasin; T W Storer; M Javanbakht; N Berman; K E Yarasheski; J Phillips; M Dike; I Sinha-Hikim; R Shen; R D Hays; G Beall
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 5.  Male hypogonadism associated with advanced cancer: a systematic review.

Authors:  Antonio Vigano; Melissa Piccioni; Barbara Trutschnigg; Laura Hornby; Prosanto Chaudhury; Robert Kilgour
Journal:  Lancet Oncol       Date:  2010-06-10       Impact factor: 41.316

6.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

Authors:  Yasemin Sancak; Carson C Thoreen; Timothy R Peterson; Robert A Lindquist; Seong A Kang; Eric Spooner; Steven A Carr; David M Sabatini
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

Review 7.  Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass.

Authors:  Robert A Frost; Charles H Lang
Journal:  J Appl Physiol (1985)       Date:  2007-03-01

8.  Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles.

Authors:  J Antonio; J D Wilson; F W George
Journal:  J Appl Physiol (1985)       Date:  1999-12

9.  Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1.

Authors:  Hongmei Wang; Neil Kubica; Leif W Ellisen; Leonard S Jefferson; Scot R Kimball
Journal:  J Biol Chem       Date:  2006-10-30       Impact factor: 5.157

10.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

View more
  75 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  Cold-water immersion blunts and delays increases in circulating testosterone and cytokines post-resistance exercise.

Authors:  Jacob E Earp; Disa L Hatfield; Andrew Sherman; Elaine C Lee; William J Kraemer
Journal:  Eur J Appl Physiol       Date:  2019-06-20       Impact factor: 3.078

Review 3.  Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.

Authors:  Serge Ostrovidov; Vahid Hosseini; Samad Ahadian; Toshinori Fujie; Selvakumar Prakash Parthiban; Murugan Ramalingam; Hojae Bae; Hirokazu Kaji; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2014-02-24       Impact factor: 6.389

4.  Disruptions to the limb muscle core molecular clock coincide with changes in mitochondrial quality control following androgen depletion.

Authors:  Michael L Rossetti; Karyn A Esser; Choogon Lee; Robert J Tomko; Alexey M Eroshkin; Bradley S Gordon
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-30       Impact factor: 4.310

5.  Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells.

Authors:  Ruisong Ye; Min Pi; Mohammed M Nooh; Suleiman W Bahout; L Darryl Quarles
Journal:  Mol Pharmacol       Date:  2019-03-20       Impact factor: 4.436

Review 6.  Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.

Authors:  Bradley S Gordon; Jennifer L Steiner; David L Williamson; Charles H Lang; Scot R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-17       Impact factor: 4.310

Review 7.  Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

Authors:  Stephen E Borst; Joshua F Yarrow
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

8.  Understanding Sarcopenia Development: A Role for Healthy Behaviors.

Authors:  Justin P Hardee; James A Carson
Journal:  Am J Lifestyle Med       Date:  2017-01-10

9.  Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.

Authors:  James P White; Melissa J Puppa; Song Gao; Shuichi Sato; Stephen L Welle; James A Carson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

10.  Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.

Authors:  Archana Vijayakumar; Nicholas J Buffin; Emily J Gallagher; Jeffrey Blank; Yingjie Wu; Shoshana Yakar; Derek LeRoith
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.